| ISSN |
1949-8462 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Cardiac & Cardiovascular Systems |
| Manuscript Type |
Meta-Analysis |
| Article Title |
Long-term prognostic role of adiponectin in stable coronary artery disease: A meta-analysis of prospective studies
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Sahas Reddy Jitta, Priyanka Vatsavayi, Chenna Reddy Tera, Shobana Krishnamurthy, Saisree Reddy Adla Jala, Diksha Sanjana Pasnoor, Utheja Dasari, Aisha Farooq, Supriya Maramreddy, Kavya Jammula, Medha Reddy Kesani, Sridevi Tripuraneni, Nihar Jena and Rupak Desai |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Rupak Desai, Department of Outcomes Research, Independent Researcher, Decatur, Atlanta, GA 30033, United States. drrupakdesai@gmail.com |
| Key Words |
Adiponectin; Stable coronary artery disease; Coronary artery disease; Major adverse cardiac and cerebrovascular events; Mortality; Long-term; Systematic review; Meta-analysis |
| Core Tip |
The persistent burden of cardiovascular (CV) disease in the United States requires innovative and cost-effective prognostic markers that can be relied upon. Higher levels of adiponectin are associated with increased long-term mortality and major adverse CV events in patients with coronary artery disease. This highlights adiponectin as a potential cost-effective prognostic marker for risk assessment and treatment guidance. |
| Publish Date |
2025-06-20 07:30 |
| Citation |
<p>Jitta SR, Vatsavayi P, Tera CR, Krishnamurthy S, Adla Jala SR, Pasnoor DS, Dasari U, Farooq A, Maramreddy S, Jammula K, Kesani MR, Tripuraneni S, Jena N, Desai R. Long-term prognostic role of adiponectin in stable coronary artery disease: A meta-analysis of prospective studies. <i>World J Cardiol</i> 2025; 17(6): 105452</p> |
| URL |
https://www.wjgnet.com/1949-8462/full/v17/i6/105452.htm |
| DOI |
https://dx.doi.org/10.4330/wjc.v17.i6.105452 |
